This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...
Tag: Healthcare
Microsoft Is Aggressively Investing In Healthcare AI
Earlier this month, healthcare artificial intelligence (AI) company Paige announced a new partnership with renowned technology giant, Microsoft. Paige describes itself as a company at the forefront of...
Tesla, AT&T, Visa, Chevron, Microsoft, and More Stocks to Watch This Week
We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We’ve detected you are on Internet Explorer. For the best Barrons.com e...
Tesla, AT&T, Visa, Chevron, Microsoft, and More Stocks for Investors to Watch This Week
We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We’ve detected you are on Internet Explorer. For the best Barrons.com e...
GE HealthCare Stock Spin-Off Showing Key Technical Strength
On Friday, GE HealthCare Techs (GEHC) reached a key performance benchmark, with its Relative Strength (RS) Rating moving into the 80-plus percentile with an improvement to 81, up from 71 the day befor...
GE set to report final pre-breakup earnings
General Electric Co. is scheduled to report next week its final quarterly results before the start of its breakup, with the industrial conglomerate expected to report its highest profit since before t...
CureVac Stock Just Got Upgraded. It’s Now a Competitor in mRNA Vaccines.
CureVac is ready to compete in the big leagues with its vaccines, according to a UBS analyst who says the soaring stock has more room to rise. UBS analyst Eliana Merle upgraded the shares (ticker: CVA...
First XRPL Healthcare Marketplace Set To Launch With ScriptCo Partnership
– Advertisement – XRP Healthcare will allow users to purchase pharmaceutical products and healthcare services using its native token. XRP Healthcare, a London-based Web 3 company focused o...
Exxon Mobil Stock Should Shine, Even in a Recession
These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...
Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.
Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...
Analysts Just Upgraded These 3 Healthcare REITs
A new year often brings new hope for the stock market, and after the terrible performance of real estate investment trusts (REITs) in 2022, it’s refreshing to see analysts coming out with improved for...
GE HealthCare, in first deal after spinoff, set to buy French company
GE HealthCare Technologies Inc. GEHC, -1.44% late Monday said it has agreed to buy French tomography company IMACTIS for an undisclosed amount. IMACTIS’s system is designed to increase the procedure’s...
Fed’s Powell won’t stop rate hikes until he ‘terrifies’ the wealthiest of investors, says this CIO
Investors are waking up to a whiff of positivity where stocks are concerned for Monday, after last week’s first gain in five that was prompted by weak wage growth Alongside a bleak Institute for Suppl...
Cardano Receives Major Boost, ADA to Be Adopted for Healthcare Payments
Hoskinson says his new clinic will accept ADA from customers, as a payment method for the medical services they receive. The rate of adoption of ADA – the native token of the Cardano ecosystem, may ha...
European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas
European drugmakers on Monday announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums. Anglo-Swedish AstraZeneca AZN, +1.42% AZN, -1.26% said it’s pay...
The Stock Market Had a Great Start to 2023. Earnings Season Could Be a Problem.
Text size This coming Friday marks the start of fourth-quarter earnings season, with Jamie Dimon’s JPMorgan Chase helping to kick off the festivities. Ting Shen/Bloomberg Investors got their Goldilock...
It’s Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.
My 2023 biotech outlook calls for continued momentum in name changes. I just need to figure out what the stocks will do. Last year, Respira Technologies became Qnovia. It’s run by a former tobacco exe...
AbbVie cuts earnings forecast due to milestone payments
AbbVie Inc. executives lowered their outlook for the quarter and year in a filing with the Securities and Exchange Commission late Friday, which cited research and development expenses and milestone p...
GE HealthCare Jumps in Trading Debut After Spinoff
(Bloomberg) — General Electric Co.’s former medical-equipment business surged in its trading debut as investors got their first chance to bet on the now-independent company. Most Read from Bloom...
GE HealthCare begins trading as spin-off heralds shift to corporate streamlining
A longstanding medical tech maker is now set to make its own moves. GE HealthCare made its market debut on Wednesday under the ticker symbol GEHC, finalizing a spin-off from General Electric (GE), whi...
GE Healthcare is ‘well-positioned for above average profitability’
General Electric Company (NYSE: GE) tanked 20% on Wednesday after it completed the spin-off of its healthcare unit. Expert shares his outlook on GE Healthcare GE Healthcare Technologies Inc debuted on...
These 15 Dividend Aristocrat stocks have been the best income builders
The S&P Dividend Aristocrats deserve more coverage. Those are companies that have raised their dividend payouts consistently over the years — they’re dividend royalty, as it were. As a group, they...